Azora Therapeutics, Inc. (AZR)
NASDAQ · Manufacturing · Pharmaceutical preparations
AZR price, last 12 months
Key stats
- Previous close
- $3.80
- Open
- $4.10
- Day range
- $3.60 – $4.10
- 52-week range
- $3.02 – $4.97
- Volume
- 86K
- Avg volume (20 days)
- —
- Market cap
- $10.7M
Performance
About Azora Therapeutics, Inc.
Azora Therapeutics Inc is a biopharmaceutical company focused on developing treatments for serious inflammatory diseases. Azora owns the royalty-free rights to its technology, which is based on the development of potential best-in-class oral agonists of the aryl hydrocarbon receptor. Azora's lead program is AT177, a proprietary colon-targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure in development for ulcerative colitis.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $10.7M